India has so far administered 1,650,487,260 vaccine doses. That is 4039.54 per cent of its total caseload, and 117.8 per cent of its population
The states informed the minister that door-to-door surveys, multi-department groups for monitoring households and several war rooms are some of the initiatives they have taken
The daily vaccination tally is expected to increase with the compilation of the final reports for the day
Union Health Minister Mansukh Mandaviya congratulated the children, saying Young India showed the way
A team of international researchers have found that the novel coronavirus can continue to be present in some human bodies upto 232 days.
He also said more than the projected requirements of Covid vaccine doses were provided to the states and the UTs
Union Health Minister asked the southern states to focus on the 5-fold strategy of 'Test-Track-Treat-Vaccinate and Adherence to Covid Appropriate Behaviour' along with effective surveillance
India has so far administered 1,644,473,216 vaccine doses. That is 4048.16 per cent of its total caseload, and 117.37 per cent of its population
In metros such as Delhi and Mumbai, the positivity rate has been declining over the last week
The prevalence of Omicron sub-lineage BA.2 is gradually increasing in India, said Sujeet Kumar Singh, Director, National Centre for Disease Control (NCDC), here on Thursday.
Kerala logged 51,739 fresh COVID-19 cases on Thursday taking the caseload to 58,26,596, while the death toll rose to 52,343 with 68 COVID-19-related deaths being registered.
A new study has found the drugs behind the new pills to treat COVID-19 remain very effective against the Omicron variant of the virus in lab tests.The research has been published in the 'New England Journal of Medicine'.However, lab tests also showed that the available antibody therapies -- typically given intravenously in hospitals -- are substantially less effective against omicron than against earlier variants of the virus. Some antibodies have entirely lost their ability to neutralize omicron at realistic dosages.If the ability of the antiviral pills to combat omicron is confirmed in human patients, it would be welcome news. Public health officials expect the pills to become an increasingly common treatment for COVID-19 that will reduce the severity of the disease in at-risk patients and decrease the burden of the pandemic.For now, the pills remain in short supply during the current omicron wave, which has broken case records in the U.S. and other countries.The findings ...
India has so far administered 1,638,439,207 vaccine doses. That is 4087.4 per cent of its total caseload, and 116.94 per cent of its population
Delhi reported 7,498 fresh COVID-19 cases and 29 deaths, with the positivity rate witnessing a marginal increase to 10.59 per cent, according to data
Andhra Pradesh reported 13,618 new COVID-19 cases during the last 24 hours, said the state health department on Wednesday.With this, the total COVID-19 cases in the state have gone up to 22,22,573, including 1,06,318 active cases.During the last 24 hours, 8,687 people recovered from the infection, taking the total recoveries in the state to 21,01,685.Nine people lost their lives to the deadly virus during the last 24 hours. With the addition of new fatalities, the death toll in the state mounted to 14,570.
India has so far administered 1,635,844,536 vaccine doses. That is 4080.92 per cent of its total caseload, and 116.75 per cent of its population
India has so far administered 1,629,209,308 vaccine doses. That is 4093.57 per cent of its total caseload, and 116.28 per cent of its population
Delhi on Monday reported 5,760 new Covid cases and 30 deaths, while the positivity rate dropped to 11.79 per cent, according to data shared by the health department.
Twenty-one COVID-19 cases caused by the Omicron variant's sub-lineage known as BA.2 have been found in tests conducted over the past 18 days in the laboratory of a private medical institute
People vaccinated three times or immunised after an earlier COVID-19 infection have comparable neutralising antibody response to those with a breakthrough infection, according to a study.